Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics

Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics

Introduction: Shizao decoction (SZD) is a traditional Chinese medicine decoction that has therapeutic effects on cirrhotic ascites (CAS). Because of the unclear treatment mechanism, in the current study, the anti-CAS activity of SZD and molecular mechanisms were analyzed by network analysis combined...

Full description

Bibliographic Details
Main Authors:	Wenjing Li, Yujiao Hou, Yanping Wang, Ronghong Liu, Han Zhang, Yanqiong Luo, Qian Li, Mosesmanaanye Njolibimi, Bo Hong, Tao Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	Shizao decoction pharmacokinetics metabolomic network analysis cirrhotic ascites
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1298818/full

Similar Items

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats
by: Yi Ying, et al.
Published: (2023-02-01)

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial
by: Jieting Tang, et al.
Published: (2020-11-01)

The Role of Serum Ascites Albumin Gradient in the Differential Diagnosis of Ascites.
by: Hysni Dede, et al.
Published: (2022-01-01)

Recent insights into contributing factors in the pathogenesis of cirrhotic ascites
by: Zhen Li, et al.
Published: (2024-09-01)

A Metabolomic Analysis of Cirrhotic Ascites
by: Diren Beyoğlu, et al.
Published: (2022-06-01)

Non-Cirrhotic Ascites: Causes and Management
by: Paul Carrier, et al.
Published: (2024-10-01)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
by: Bisha Ding, et al.
Published: (2019-07-01)

ASCITES IN THE CIRRHOTIC PATIENT: HOW TO APPROACH IT? (IN SPANISH)
by: Yepes-Barreto Ismael, et al.
Published: (2014-06-01)

Ascites in cirrhotic patients: a comprehensive review
by: Paul Carrier, et al.
Published: (2024-08-01)

Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal
by: Qiang Zhao, et al.
Published: (2020-02-01)

Echocardiographic Findings in Cirrhotic Patients with and without Ascites Compared to Normal
by: M Kashifard, et al.
Published: (2010-10-01)

Inguinal hernia repair in cirrhotic patients with ascites
by: Junsheng Li, et al.
Published: (2020-01-01)

QT Interval Prolongation in Cirrhotic Cardiomyopathy
by: Tadelle A
Published: (2022-07-01)

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
by: Jing-Ze Lu, et al.
Published: (2021-05-01)

The Effect of Yinchenhao Decoction on the Pharmacokinetic Profile of Futibatinib by HPLC-MS/MS
by: Chunfu Wang, et al.
Published: (2024-07-01)

Management of refractory cirrhotic ascites: challenges and solutions
by: Fukui H, et al.
Published: (2018-07-01)

Role of ascitic endocan level in diagnosis of spontaneous bacterial peritonitis in patients with cirrhotic ascites
by: WU Xianmei, et al.
Published: (2020-07-01)

Prevalence of glucose intolerance in cirrhotics and risk factors predicting its progression to diabetes mellitus
by: Pavan Hanchanale, et al.
Published: (2017-01-01)

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model
by: Nan Xu, et al.
Published: (2024-01-01)

Comparative Pharmacokinetics of Hypaconitine after Oral Administration of Pure Hypaconitine, Aconitum carmichaelii Extract and Sini Decoction to Rats
by: Wen Zhang, et al.
Published: (2015-01-01)

SPONTANEOUS BACTERIAL PERITONITIS IN ASYMPTOMATIC CIRRHOTIC PATIENTS WITH ASCITES IN A TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY
by: Asif Aziz, et al.
Published: (2020-10-01)

Ascitic calprotectin as a diagnostic marker for spontaneous bacterial peritonitis in hepatitis C virus cirrhotic Egyptian patients
by: Ahmed A Heikl, et al.
Published: (2018-01-01)

Ayurvedic management of cirrhotic ascites
by: G Aswathy, et al.
Published: (2016-01-01)

Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations
by: Yiyu Qi, et al.
Published: (2019-12-01)

Shengqing Jiangzhuo decoction regulates the immunosuppressive microenvironment via the STAT3 signaling pathway for the treatment of malignant ascites in HCC
by: Gaofei Feng, et al.
Published: (2024-09-01)

Preparation, Characterization and Pharmacokinetic Study of Xiangfu Siwu Decoction Essential Oil/β-Cyclodextrin Inclusion Complex
by: Junzuan Xi, et al.
Published: (2015-06-01)

Relevance of the Pharmacokinetic and Pharmacodynamic Profiles of Puerariae lobatae Radix to Aggregation of Multi-Component Molecules in Aqueous Decoctions
by: Bili Su, et al.
Published: (2016-06-01)

Simultaneous Determination of Seven Components in Rat Plasma by the UPLC-MS/MS Method and Application of Pharmacokinetic Studies to SimiaoYong’an Decoction
by: Yuanyan Liu, et al.
Published: (2017-11-01)

Survival benefit associated with early detection of spontaneous bacterial peritonitis in veteran inpatients with cirrhotic ascites
by: Luke Townsend, et al.
Published: (2020-06-01)

Ascites Index – an attempt to objectify the assessment of ascites
by: Piotr Szkodziak, et al.
Published: (2018-06-01)

Pasteurella multocida peritonitis after cat scratch in a patient with cirrhotic ascites
by: Roshan Gunathilake, et al.
Published: (2015-06-01)

Regulation of polysaccharide in Wu‐tou decoction on intestinal microflora and pharmacokinetics of small molecular compounds in AIA rats
by: Di Yang, et al.
Published: (2024-01-01)

D-dimers and ferritin: Expanding the diagnostic panel for cirrhotic ascites evaluation
by: Trifonov Petar, et al.
Published: (2023-07-01)

Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF–MS/MS and UHPLC-Q-TRAP-MS/MS
by: Yan He, et al.
Published: (2022-10-01)

Joint Group and Multi Institutional Position Opinion: Cirrhotic Cardiomyopathy—From Fundamentals to Applied Tactics
by: Ivan Rankovic, et al.
Published: (2024-12-01)

Assessment of calprotectin in ascitic fluid as a marker for spontaneous bacterial peritonitis diagnosis in cirrhotic patients
by: Fayrouz O Selim, et al.
Published: (2018-01-01)

Non-cirrhotic portal fibrosis
by: Venkatesan Mukta, et al.
Published: (2014-01-01)

Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites
by: Yanfei Chen, et al.
Published: (2018-11-01)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

NON-SELECTIVE BETA-BLOCKERS IN CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES: WHERE ARE WE?
by: Athina Gomes MAIA, et al.
Published: (2024-07-01)